$PMDI
PSYCHEMEDICS CORP

2014 Q4 Form 10-Q Financial Statement

#000114420414064200 Filed on October 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q4
Revenue $6.762M $7.704M $6.484M
YoY Change 4.29% 9.2% 14.6%
Cost Of Revenue $3.280M $3.734M $2.830M
YoY Change 15.9% 29.71% -2.08%
Gross Profit $3.482M $3.970M $3.652M
YoY Change -4.65% -4.93% 32.03%
Gross Profit Margin 51.49% 51.53% 56.32%
Selling, General & Admin $2.160M $2.362M $2.350M
YoY Change -8.09% 5.73% 8.8%
% of Gross Profit 62.03% 59.49% 64.35%
Research & Development $360.0K $363.8K $270.0K
YoY Change 33.33% 78.97% 80.0%
% of Gross Profit 10.34% 9.16% 7.39%
Depreciation & Amortization $300.0K $280.0K $230.0K
YoY Change 30.43% 27.27% 35.29%
% of Gross Profit 8.62% 7.05% 6.3%
Operating Expenses $2.520M $2.725M $2.620M
YoY Change -3.82% 11.84% 13.91%
Operating Profit $958.0K $1.244M $1.033M
YoY Change -7.26% -28.46% 122.63%
Interest Expense -$30.00K $33.94K $0.00
YoY Change
% of Operating Profit -3.13% 2.73% 0.0%
Other Income/Expense, Net
YoY Change
Pretax Income $930.0K $1.210M $1.030M
YoY Change -9.71% -30.43% 123.91%
Income Tax $250.0K $293.4K $170.0K
% Of Pretax Income 26.88% 24.24% 16.5%
Net Earnings $676.0K $917.0K $868.0K
YoY Change -22.12% -12.83% 217.95%
Net Earnings / Revenue 10.0% 11.9% 13.39%
Basic Earnings Per Share $0.13 $0.17 $0.16
Diluted Earnings Per Share $0.13 $0.17 $0.16
COMMON SHARES
Basic Shares Outstanding 5.375M shares 5.375M shares
Diluted Shares Outstanding 5.389M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.610M $2.610M $3.970M
YoY Change -9.07% -8.1% 29.32%
Cash & Equivalents $3.612M $2.612M $3.971M
Short-Term Investments
Other Short-Term Assets $1.070M $1.510M $1.060M
YoY Change 0.94% 5.59% 2.91%
Inventory
Prepaid Expenses
Receivables $4.078M $5.760M $4.369M
Other Receivables $1.820M $0.00 $550.0K
Total Short-Term Assets $10.58M $9.880M $9.956M
YoY Change 6.23% 3.38% 3.99%
LONG-TERM ASSETS
Property, Plant & Equipment $12.74M $12.83M $6.050M
YoY Change 110.57% 158.96% 44.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $761.0K $730.0K $543.3K
YoY Change 40.06% 32.02% 57.36%
Total Long-Term Assets $13.50M $13.55M $6.594M
YoY Change 104.76% 146.03% 45.02%
TOTAL ASSETS
Total Short-Term Assets $10.58M $9.880M $9.956M
Total Long-Term Assets $13.50M $13.55M $6.594M
Total Assets $24.08M $23.43M $16.55M
YoY Change 45.49% 55.53% 17.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $845.1K $680.0K $510.6K
YoY Change 65.52% 17.83% -23.77%
Accrued Expenses $1.351M $1.970M $2.448M
YoY Change -44.8% 23.24% 73.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.400M $1.400M $0.00
YoY Change
Total Short-Term Liabilities $3.596M $4.055M $2.958M
YoY Change 21.56% 86.39% 42.01%
LONG-TERM LIABILITIES
Long-Term Debt $4.848M $5.198M $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.848M $5.198M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.596M $4.055M $2.958M
Total Long-Term Liabilities $4.848M $5.198M $0.00
Total Liabilities $11.24M $10.57M $4.273M
YoY Change 163.09% 253.41% 47.44%
SHAREHOLDERS EQUITY
Retained Earnings -$6.566M -$6.436M -$6.560M
YoY Change 0.09% -2.94% -8.72%
Common Stock $29.48M $29.38M $28.92M
YoY Change 1.96% 2.05% 1.5%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M $10.08M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 668.1K shares 668.1K shares 668.1K shares
Shareholders Equity $12.84M $12.86M $12.28M
YoY Change
Total Liabilities & Shareholders Equity $24.08M $23.43M $16.55M
YoY Change 45.49% 55.52% 17.2%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q4
OPERATING ACTIVITIES
Net Income $676.0K $917.0K $868.0K
YoY Change -22.12% -12.83% 217.95%
Depreciation, Depletion And Amortization $300.0K $280.0K $230.0K
YoY Change 30.43% 27.27% 35.29%
Cash From Operating Activities $2.500M $1.760M $2.100M
YoY Change 19.05% 3.53% 244.26%
INVESTING ACTIVITIES
Capital Expenditures -$240.0K -$1.290M -$150.0K
YoY Change 60.0% 89.71% -59.46%
Acquisitions
YoY Change
Other Investing Activities -$40.00K -$50.00K $0.00
YoY Change -61.54% -100.0%
Cash From Investing Activities -$290.0K -$1.340M -$160.0K
YoY Change 81.25% 67.5% -61.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.210M -160.0K -820.0K
YoY Change 47.56% -79.49% 3.8%
NET CHANGE
Cash From Operating Activities 2.500M 1.760M 2.100M
Cash From Investing Activities -290.0K -1.340M -160.0K
Cash From Financing Activities -1.210M -160.0K -820.0K
Net Change In Cash 1.000M 260.0K 1.120M
YoY Change -10.71% 116.67% -286.67%
FREE CASH FLOW
Cash From Operating Activities $2.500M $1.760M $2.100M
Capital Expenditures -$240.0K -$1.290M -$150.0K
Free Cash Flow $2.740M $3.050M $2.250M
YoY Change 21.78% 28.15% 129.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1075133 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1155099 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3435257 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3470588 USD
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5375061 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5389425 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
751306 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1955897 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6993673 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
1400000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
1400000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
1400000 USD
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
872521 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6043191 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5981896 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668130 shares
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20386381 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
22443005 USD
CY2013Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7055202 USD
us-gaap Cost Of Services
CostOfServices
8644109 USD
us-gaap Cost Of Services
CostOfServices
10786382 USD
us-gaap Gross Profit
GrossProfit
11742272 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4368864 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
1400000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
648000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3970512 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
769269 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
554828 USD
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
292795 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
9956268 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6050203 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
543345 USD
CY2013Q4 us-gaap Assets
Assets
16549816 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
510550 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2447920 USD
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1399925 USD
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4055036 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2958470 USD
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5198139 USD
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1314221 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
1314221 USD
CY2014Q3 us-gaap Liabilities
Liabilities
10567396 USD
CY2013Q4 us-gaap Liabilities
Liabilities
4272691 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
30216 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
29910 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29347419 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
28888712 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6435737 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6559708 USD
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10081789 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10081789 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
12860109 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
12277125 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23427505 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16549816 USD
CY2014Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
404560 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
26000 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
19000 shares
CY2014Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
167000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
153000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
182000 shares
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
350000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6598000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1400000 USD
CY2014Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
1052943 USD
CY2014Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
1935241 USD
CY2014Q2 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
3011816 USD
CY2014Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
999626 USD
CY2014Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
7000000 USD
CY2014Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0215 pure
us-gaap Interest Expense
InterestExpense
46958 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
33941 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
102635 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
144921 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5801269 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5175722 USD
CY2014Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7704047 USD
CY2013Q3 us-gaap Cost Of Services
CostOfServices
2879150 USD
CY2014Q3 us-gaap Cost Of Services
CostOfServices
3734470 USD
us-gaap Gross Profit
GrossProfit
11656623 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
4176052 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
3969577 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3075794 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3467863 USD
CY2013Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1158355 USD
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1206479 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
558011 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
986201 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
203265 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
363788 USD
us-gaap Operating Expenses
OperatingExpenses
7069062 USD
us-gaap Operating Expenses
OperatingExpenses
7924652 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
2436753 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2725366 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4673210 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3731971 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1739299 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1244211 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
91993 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
-29157 USD
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
280 USD
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
-33941 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4765203 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3702814 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1739579 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1210270 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1827932 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1172836 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
687579 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
293370 USD
us-gaap Net Income Loss
NetIncomeLoss
2937271 USD
us-gaap Net Income Loss
NetIncomeLoss
2529978 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
1052000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
916900 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.47
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5301330 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5348730 shares
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
202283 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1603314 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-92708 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
172696 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
184916 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7517350 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-667621 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
155217 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
176648 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3852525 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
835735 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
540097 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
321394 USD
us-gaap Payments To Acquire Assets Investing Activities
PaymentsToAcquireAssetsInvestingActivities
227482 USD
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5312105 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5314224 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5375472 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5330515 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
642580 USD
us-gaap Share Based Compensation
ShareBasedCompensation
386297 USD
us-gaap Share Based Compensation
ShareBasedCompensation
448417 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
672737 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1388452 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-622123 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-286221 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20839 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
47564 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-111249 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-36968 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2381845 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2406007 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2472255 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4202653 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-223044 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1358800 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3065785 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2842741 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
643000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
461920 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
42285 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
170642 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
191566 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
PSYCHEMEDICS CORP
dei Entity Central Index Key
EntityCentralIndexKey
0000806517
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
PMD
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5375061 shares
CY2014Q3 us-gaap Debt Instrument Increase Decrease For Period Net
DebtInstrumentIncreaseDecreaseForPeriodNet
1500000 USD

Files In Submission

Name View Source Status
0001144204-14-064200-index-headers.html Edgar Link pending
0001144204-14-064200-index.html Edgar Link pending
0001144204-14-064200.txt Edgar Link pending
0001144204-14-064200-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pmd-20140930.xml Edgar Link completed
pmd-20140930.xsd Edgar Link pending
pmd-20140930_cal.xml Edgar Link unprocessable
pmd-20140930_def.xml Edgar Link unprocessable
pmd-20140930_lab.xml Edgar Link unprocessable
pmd-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v391587_10q.htm Edgar Link pending
v391587_ex31-1.htm Edgar Link pending
v391587_ex31-2.htm Edgar Link pending
v391587_ex32-1.htm Edgar Link pending
v391587_ex32-2.htm Edgar Link pending